Sarah B. Noonberg

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Donna M. Cochener, as attorney-in-fact for Sarah B. Noonberg
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah B. Noonberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi, Inc. Chief Medical Officer Common Stock 109,135 $190,986 $1.75 06 Jun 2025 Direct
MARINUS PHARMACEUTICALS, INC. Director Common Stock 14,100 $60,348 $4.28 18 Jun 2024 Direct
Metagenomi, Inc. Chief Medical Officer Stock Option (Right to Buy) 84,000 01 Apr 2025 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 30,000 16 Jan 2023 Direct
Neurogene Inc. Director Non-Qualified Stock Option (right to buy) 12,050 12 Jun 2025 Direct
MARINUS PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 10,450 18 Jun 2024 Direct
Neurogene Inc. Director Stock Option (Right to Buy) 7,700 14 Jun 2024 Direct

Insider Reports Filed by Sarah B. Noonberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NGNE Neurogene Inc. 12 Jun 2025 1 $0 4 Director 13 Jun 2025, 12:05
MGX Metagenomi, Inc. 06 Jun 2025 1 -$9,168 4 Chief Medical Officer 09 Jun 2025, 18:57
MGX Metagenomi, Inc. 01 Apr 2025 2 $0 4 Chief Medical Officer 03 Apr 2025, 11:56
MRNS MARINUS PHARMACEUTICALS, INC. 18 Jun 2024 2 $0 4 Director 20 Jun 2024, 16:27
NGNE Neurogene Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 14:36
MGX Metagenomi, Inc. 01 Apr 2024 2 $0 4 Chief Medical Officer 03 Apr 2024, 20:47
MGX Metagenomi Technologies, LLC 08 Feb 2024 0 $0 3 Chief Medical Officer 08 Feb 2024, 19:26
MRNS MARINUS PHARMACEUTICALS, INC. 18 Jan 2024 2 $0 4 Director 19 Jan 2024, 16:28
NGNE Neurogene Inc. 16 Jan 2024 1 $0 4 Director 18 Jan 2024, 18:56
NLTX Neoleukin Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:26
MRNS MARINUS PHARMACEUTICALS, INC. 16 May 2023 2 $0 4 Director 17 May 2023, 21:08
MRNS MARINUS PHARMACEUTICALS, INC. 16 May 2023 0 $0 3 Director 17 May 2023, 21:02
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 1 $0 4 Director 18 Jan 2023, 19:03
PTGX Protagonist Therapeutics, Inc 26 May 2022 1 $0 4 Director 27 May 2022, 16:01
NLTX Neoleukin Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 18:24
PTGX Protagonist Therapeutics, Inc 27 May 2021 1 $0 4 Director 28 May 2021, 18:43
NLTX Neoleukin Therapeutics, Inc. 11 May 2021 1 $0 4 Director 13 May 2021, 17:37